Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EFITA: Mosquito Transmissibility of P. falciparum after Piperaquine
NCT02431637Phase 1Completed
- Sponsor
- Medicines for Malaria Venture
- Start
- Apr 2015
- Primary completion
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of piperaquine in malaria, sponsored by Medicines for Malaria Venture. Primary endpoint: Successful Infection of Vector Mosquitoes Following Both Direct and Indirect Feeding on the Blood of Infected Participants. Started Apr 2015; status: completed.
02
Drugs
piperaquine
03
Conditions
malaria
Beyond the preview
Go deeper on NCT02431637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02431637.